Monitoring bone defects of the femur before hip revision and bone growth after hip revision arthroplasty with DEXA, a pilot study

Completed

• Conditions: hip revision arthroplasty; 10005959

• Registration Number: NL-OMON39308
• Lead Sponsor: Reinier de Graaf Groep

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 25

Inclusion Criteria

The hospital criteria and protocol for patients who are diagnosed for a total hip revision will be applied.
- Diminished femoral bone stock
- patients needing revision surgery
- Patient aged 18y and older
- Patient willing to participate
- No active infection
- ASA I-III

Exclusion Criteria

- Patients unwilling to participate
- Mentally retarded
- Patients with sufficient bone stock
- ASA IV / V

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study parameters are bone mineral density and bone mineral content. It is<br /><br>expected that these DEXA results of the revised hip after 24 months will be<br /><br>comparable to DEXA results of the contralateral hip. Bone mineral density and<br /><br>bone mineral content will increase in time when DEXA scans after surgery are<br /><br>compared. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>